We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current XTNT market cap is 70.99M. The company's latest EPS is USD 0.0047 and P/E is 110.64.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 25.02M | 28.11M | 27.87M | 29.94M | 27.94M |
| Operating Income | -3.39M | -3.81M | -3.47M | -2.95M | -3.78M |
| Net Income | 9.23M | -4.3M | -4.4M | -3.86M | -5.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 64.68M | 53.34M | 55.26M | 57.97M | 91.3M |
| Operating Income | -2.25M | -751k | -3.85M | -6.76M | -10.16M |
| Net Income | -8.22M | -7.02M | -4.85M | -8.49M | 660k |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 92M | 92.61M | 93.93M | 95.58M | 98.88M |
| Total Liabilities | 37.32M | 41.26M | 46.25M | 50.57M | 53.16M |
| Total Equity | 54.68M | 51.35M | 47.68M | 45.01M | 45.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 43.16M | 41.47M | 54.69M | 60.23M | 92.61M |
| Total Liabilities | 87.36M | 26.95M | 23.81M | 26.06M | 41.26M |
| Total Equity | -44.21M | 14.51M | 30.88M | 34.17M | 51.35M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.6M | -9.52M | -5.76M | -10.84M | -12.56M |
| Investing | -22.47M | -24.78M | -674k | -1.15M | -3.16M |
| Financing | 19.37M | 19.69M | 5.18M | 11.61M | 16.93M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -413k | -731k | 439k | -5.34M | -9.52M |
| Investing | -544k | -1.3M | -1.89M | -1.56M | -24.78M |
| Financing | -603k | -861k | 17.5M | 9.02M | 19.69M |
| Market Cap | 70.99M |
| Price to Earnings Ratio | 110.64 |
| Price to Sales Ratio | 0.79 |
| Price to Cash Ratio | 12.65 |
| Price to Book Ratio | 1.41 |
| Dividend Yield | - |
| Shares Outstanding | 139.01M |
| Average Volume (1 week) | 29.37k |
| Average Volume (1 Month) | 52.15k |
| 52 Week Change | -50.89% |
| 52 Week High | 1.2999 |
| 52 Week Low | 0.331 |
| Spread (Intraday) | 0.06 (10.31%) |
| Company Name | Xtant Medical Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://xtantmedical.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
